| |
| |
|
| Insider
Information: |
Clarke John K |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
97,811 |
|
|
Indirect Shares
|
2,446,095 |
|
|
| Direct
Value |
$4,925,446 |
|
|
|
Indirect Value
|
$25,157,127 |
|
|
| Total
Shares |
2,543,906 |
|
|
| Total
Value |
$30,082,573 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2015-05-12 |
69,123 |
2006-11-20 |
0 |
Premium* |
|
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2018-05-31 |
8,891 |
2014-05-21 |
8,891 |
Premium* |
|
|
Visicu Inc |
EICU |
Director, 10% Owner |
2008-02-20 |
0 |
2008-02-20 |
0 |
Premium* |
|
|
Verastem, Inc. |
VSTM |
Director |
2012-02-01 |
0 |
2013-06-12 |
2,329,121 |
Premium* |
|
|
aTyr Pharma Inc |
LIFE |
Director |
2023-04-26 |
19,797 |
2021-05-21 |
108,083 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2023-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
19,797 |
0 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2021-05-21 |
4 |
S |
$4.34 |
$10,850 |
I/I |
(2,500) |
108,083 |
0 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2020-09-02 |
4 |
S |
$4.01 |
$29,113 |
I/I |
(7,260) |
110,583 |
0 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2020-08-28 |
4 |
S |
$4.00 |
$400 |
I/I |
(100) |
117,843 |
0 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2020-08-27 |
4 |
S |
$4.09 |
$22,250 |
I/I |
(5,440) |
117,943 |
0 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2020-08-26 |
4 |
S |
$4.30 |
$9,451 |
I/I |
(2,200) |
123,383 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2018-05-31 |
4 |
OE |
$27.28 |
$409,200 |
D/D |
15,000 |
23,891 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2018-05-31 |
4 |
AS |
$99.38 |
$1,504,678 |
D/D |
(15,000) |
8,891 |
0 |
- |
|
| LIFE |
aTyr Pharma Inc |
Former 10% Owner |
– • – |
2015-05-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,758,158 |
1,758,158 |
0 |
- |
|
| LIFE |
aTyr Pharma Inc |
Former 10% Owner |
– • – |
2015-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
92,306 |
104,878 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2015-05-12 |
4 |
S |
$19.96 |
$766,464 |
D/D |
(38,400) |
69,123 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2015-05-12 |
4 |
OE |
$10.44 |
$400,896 |
D/D |
38,400 |
107,523 |
0 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • • |
2015-05-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,572 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2014-05-21 |
4 |
AS |
$52.95 |
$1,882,979 |
D/D |
(35,000) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2014-05-21 |
4 |
OE |
$7.08 |
$456,850 |
D/D |
35,000 |
35,000 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2013-06-12 |
4 |
B |
$9.60 |
$222,425 |
I/I |
23,171 |
2,329,121 |
2.1 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2013-06-11 |
4 |
B |
$9.22 |
$230,477 |
I/I |
25,000 |
2,305,950 |
2.1 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2013-05-13 |
4 |
AB |
$9.74 |
$243,375 |
I/I |
25,000 |
2,280,950 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2013-05-01 |
4 |
AB |
$9.66 |
$96,622 |
I/I |
10,000 |
2,255,950 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2013-04-17 |
4 |
B |
$9.50 |
$53,489 |
I/I |
5,631 |
2,245,950 |
2.1 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2012-12-18 |
4 |
AB |
$7.87 |
$48,739 |
I/I |
6,193 |
2,240,319 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2012-02-01 |
4 |
B |
$10.00 |
$2,500,000 |
I/I |
250,000 |
2,234,126 |
2.1 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2012-02-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,984,126 |
1,984,126 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2010-12-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,000 |
20,823 |
0 |
- |
|
| EICU |
Visicu Inc |
Director |
– • • |
2008-02-20 |
4 |
D |
$12.00 |
$600,000 |
D/D |
(50,000) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
